SPONSORS
BIOORTHOGONAL CATALYSIS - PRODRUG THERAPY
-
H2020 (MSCA-ITN THERACAT)
-
EPSRC (Healthcare Technology Challenge Award)
-
Cancer Research UK (Pioneer Award)
-
Royal Society (Research Grant)
-
Cancer Research Technology
-
Horizon 2020 (H2020-MSCA-IF-2014)
-
SULSA & Merck Sharp Dohme (Postdoctoral Award)
-
College of Medicine & Veterinary Medicine (Principal's Scholarship)
-
Alfonso Martin Escudero Foundation (Postdoctoral Award)
-
Edinburgh Cancer Research Centre (Development Fund)
-
Institute of Genetics & Molecular Medicine (HWU-IGMM Pilot Project & Lab Start-up Package)
-
College of Medicine & Veterinary Medicine (Darwin's Scholarship)
COOPERATIVE LIGAND-BASED DRUG DESIGN & PHENOTYPIC SCREENING
-
Horizon 2020 (H2020-MSCA-IF-2016)
-
Medical Research Scotland & IOmet Pharma Limited (PhD Studentship Award)
-
Breast Cancer Now (Catalyst Award)
-
Medical Research Scotland (Undergraduate Vacation Scholarship Awards)
-
College of Medicine & Veterinary Medicine (Principal's Scholarship)
-
Scottish Power (Strategic Alliance Framework Agreement)
-
Edinburgh Bioquarter (Innovation Competition)
-
MRC Technology (IP Support)
-
Welcome Trust (Institutional Strategic Support Fund)
-
Medical Research Council (Doctoral Training Programme & Supplementary Funds)
